Form 4: OPKO Health Director Acquires 30,000 Stock Options
SEC Form 4 Filing
Director Roger Medel acquired 30,000 stock options in OPKO Health, Inc. on April 23, 2025.
Summary
- Roger Medel, a director of OPKO Health, Inc., acquired 30,000 stock options on April 23, 2025.
- The options have an exercise price of $1.47.
- The options become exercisable on April 23, 2026, and expire on April 22, 2035.
- The reporting person directly owns 30,000 derivative securities after the reported transaction.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard regulatory filing. The acquisition of stock options by a director can be seen as a slightly positive sign, indicating confidence in the company, but it's not a major event.
Positives
- A director increasing their holdings in the company can be seen as a positive sign of confidence in the company's future.
Industry Context
Form 4 filings are routine disclosures required by the SEC when insiders, such as directors and officers, trade in their company's stock. This filing indicates a director's acquisition of stock options, which is a common form of executive compensation.
Stakeholder Impact
- The acquisition of stock options by a director could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 04/23/2025 | Date of transaction: acquisition of stock options. |
| 04/23/2026 | Date the stock options become exercisable. |
| 04/22/2035 | Expiration date of the stock options. |
Keywords
stock options, Form 4, OPKO Health, director, acquisition, Medel
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.